Battle of the Artificial Intelligence (AI) Computing Companies: Is AMD, Broadcom, Nvidia, or Marvell the Best Stock to Buy Now?

Nvidia’s data center revenue reached $75.2B in Q1, up 92% year over year, far exceeding AMD’s $5.8B (+57%), Broadcom’s AI semiconductor revenue of $10.8B (+143%), and Marvell’s $1.8B data center revenue (+27%). The article argues Nvidia remains the best AI chip investment given its dominant scale and a forward P/E of 23x, while Broadcom also looks attractive on custom AI chip demand and AMD/Marvell appear to have more upside already priced in. Management commentary cited strong demand for custom ASICs from hyperscalers and expects further growth from Nvidia’s Vera Rubin launch.

Analysis

The key second-order read is that AI capex is bifurcating: one leg still accrues to general-purpose accelerators, but an increasing share is migrating to vertically integrated silicon where hyperscalers can arbitrage workload specificity against cost/performance. That shift is structurally bullish for the entire AI spend cycle, but it also means the value capture is moving upstream to system-level incumbents and design partners, not just the chip merchant with the best raw GPU. In practice, that should compress the addressable upside for the smaller GPU challenger set while extending the durability of demand for the dominant platform vendor.

The most interesting implication is margin dispersion. Custom silicon ramps typically look better on unit economics once volume crosses the learning curve, but they also introduce execution risk, qualification delays, and longer replacement cycles. That creates a near-term window where the broad-platform leader can keep monetizing scarcity pricing while hyperscalers are still too committed to multi-generation software stacks to fully switch away. Over the next 6-18 months, the market may overestimate how quickly custom chips can displace GPUs in training-heavy workloads and underestimate how much the platform owner benefits from being the default fallback.

On the other hand, the custom ASIC beneficiaries should not be viewed as pure second-tier plays; they are effectively picks-and-shovels on hyperscaler capex, and their revenue visibility could improve as internal silicon programs scale from pilot to production. The risk is that the market has already capitalized much of that upside into the names with the most obvious AI exposure, leaving less room for multiple expansion if growth merely meets, rather than beats, elevated expectations. A slowing in AI capex growth rates, even without an absolute decline, would hit the smaller names first because their valuations are most dependent on sustained upward revisions.

Key Decisions for Investors

• Overweight NVDA versus AMD over the next 3-6 months; use AMD as a relative short or hedge if you want AI exposure with less multiple risk, since the market is likely overpricing near-term share gains for the challenger.
• Maintain a long AVGO position as a medium-term AI infrastructure compounder, but size it below NVDA because the stock likely needs another earnings beat to re-rate meaningfully; best risk/reward is on 6-12 month horizon, not days.
• Avoid chasing MRVL after strength; use pullbacks only. The name has asymmetric downside if custom-chip ramp timing slips by even one quarter because expectations are already tied to a steep 12-18 month growth reacceleration.
• Consider a pair trade: long NVDA / short basket of AMD + MRVL for 1-2 quarters. Thesis is that platform dominance and supply chain control should outperform the more expectation-sensitive second-tier AI chip names if capex growth slows.
• For higher-risk upside, buy 6-12 month call spreads on NVDA rather than outright equity. This captures continued leadership while limiting valuation compression risk if the market rotates from 'AI scarcity' to 'AI execution' trade.